174 related articles for article (PubMed ID: 24188633)
1. Melanoma risk loci as determinants of melanoma recurrence and survival.
Rendleman J; Shang S; Dominianni C; Shields JF; Scanlon P; Adaniel C; Desrichard A; Ma M; Shapiro R; Berman R; Pavlick A; Polsky D; Shao Y; Osman I; Kirchhoff T
J Transl Med; 2013 Nov; 11():279. PubMed ID: 24188633
[TBL] [Abstract][Full Text] [Related]
2. The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis.
Vogelsang M; Martinez CN; Rendleman J; Bapodra A; Malecek K; Romanchuk A; Kazlow E; Shapiro RL; Berman RS; Krogsgaard M; Osman I; Kirchhoff T
Clin Cancer Res; 2016 Jul; 22(13):3268-80. PubMed ID: 26733611
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival.
Li B; Wang Y; Xu Y; Liu H; Bloomer W; Zhu D; Amos CI; Fang S; Lee JE; Li X; Han J; Wei Q
Int J Cancer; 2018 Jun; 142(11):2303-2312. PubMed ID: 29313974
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in TKT and DERA in the nicotinamide adenine dinucleotide phosphate pathway predict melanoma survival.
Gu N; Dai W; Liu H; Ge J; Luo S; Cho E; Amos CI; Lee JE; Li X; Nan H; Yuan H; Wei Q
Eur J Cancer; 2020 Sep; 136():84-94. PubMed ID: 32659474
[TBL] [Abstract][Full Text] [Related]
5. Melanoma susceptibility variant rs869330 in the MTAP gene is associated with melanoma outcome.
Marasigan V; Güvenç C; van den Oord JJ; Stas M; Boecxstaens V; Bechter O; Wolter P; Lambrechts D; Garmyn M
Melanoma Res; 2019 Dec; 29(6):590-595. PubMed ID: 30681428
[TBL] [Abstract][Full Text] [Related]
6. Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
Shu X; Gu J; Huang M; Tannir NM; Matin SF; Karam JA; Wood CG; Wu X; Ye Y
Carcinogenesis; 2018 May; 39(6):752-757. PubMed ID: 29635281
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in the PIWI-piRNA pathway gene DCP1A predict melanoma disease-specific survival.
Zhang W; Liu H; Yin J; Wu W; Zhu D; Amos CI; Fang S; Lee JE; Li Y; Han J; Wei Q
Int J Cancer; 2016 Dec; 139(12):2730-2737. PubMed ID: 27578485
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival.
Xu Y; Wang Y; Liu H; Shi Q; Zhu D; Amos CI; Fang S; Lee JE; Hyslop T; Li X; Han J; Wei Q
Mol Carcinog; 2018 Jan; 57(1):22-31. PubMed ID: 28796414
[TBL] [Abstract][Full Text] [Related]
9. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P
BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264
[TBL] [Abstract][Full Text] [Related]
10. Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma.
Rendleman J; Vogelsang M; Bapodra A; Adaniel C; Silva I; Moogk D; Martinez CN; Fleming N; Shields J; Shapiro R; Berman R; Pavlick A; Polsky D; Shao Y; Osman I; Krogsgaard M; Kirchhoff T
J Med Genet; 2015 Apr; 52(4):231-9. PubMed ID: 25604082
[TBL] [Abstract][Full Text] [Related]
11. Functional annotation of melanoma risk loci identifies novel susceptibility genes.
Fang S; Lu J; Zhou X; Wang Y; Ross MI; Gershenwald JE; Cormier JN; Wargo J; Sui D; Amos CI; Lee JE
Carcinogenesis; 2020 Jun; 41(4):452-457. PubMed ID: 31630191
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival.
Li H; Wang Y; Liu H; Shi Q; Xu Y; Wu W; Zhu D; Amos CI; Fang S; Lee JE; Han J; Wei Q
Int J Cancer; 2017 Mar; 140(6):1270-1279. PubMed ID: 27914105
[TBL] [Abstract][Full Text] [Related]
13. Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting.
Seviiri M; Scolyer RA; Bishop DT; Newton-Bishop JA; Iles MM; Lo SN; Stretch JR; Saw RPM; Nieweg OE; Shannon KF; Spillane AJ; Gordon SD; Olsen CM; Whiteman DC; Landi MT; Thompson JF; Long GV; MacGregor S; Law MH
J Transl Med; 2022 Sep; 20(1):403. PubMed ID: 36064556
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in the folate metabolic pathway genes predict cutaneous melanoma-specific survival.
Dai W; Liu H; Liu Y; Xu X; Qian D; Luo S; Cho E; Zhu D; Amos CI; Fang S; Lee JE; Li X; Nan H; Li C; Wei Q
Br J Dermatol; 2020 Oct; 183(4):719-728. PubMed ID: 31955403
[TBL] [Abstract][Full Text] [Related]
15. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer susceptibility loci and influence on survival.
Song N; Kim K; Shin A; Park JW; Chang HJ; Shi J; Cai Q; Kim DY; Zheng W; Oh JH
Genes Chromosomes Cancer; 2018 Dec; 57(12):630-637. PubMed ID: 30350386
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence.
Ahn J; Kibel AS; Park JY; Rebbeck TR; Rennert H; Stanford JL; Ostrander EA; Chanock S; Wang MH; Mittal RD; Isaacs WB; Platz EA; Hayes RB
Clin Cancer Res; 2011 Mar; 17(5):1075-81. PubMed ID: 21343373
[TBL] [Abstract][Full Text] [Related]
18. A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon.
Wang E; Zhao Y; Monaco A; Uccellini L; Kirkwood JM; Spyropoulou-Vlachou M; Panelli MC; Marincola FM; Gogas H
PLoS One; 2012; 7(7):e40805. PubMed ID: 22911710
[TBL] [Abstract][Full Text] [Related]
19. Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial.
Eggermont AMM; Kicinski M; Blank CU; Mandala M; Long GV; Atkinson V; Dalle S; Haydon A; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJM; Grob JJ; Gutzmer R; Jamal R; Lorigan PC; Krepler C; Ibrahim N; Marreaud S; van Akkooi A; Robert C; Suciu S
JAMA Oncol; 2020 Apr; 6(4):519-527. PubMed ID: 31895407
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations associated with postoperative recurrence in stage I non-small cell lung cancer.
Yoon KA; Jung MK; Lee D; Bae K; Joo JN; Lee GK; Lee HS; Lee JS
Clin Cancer Res; 2014 Jun; 20(12):3272-9. PubMed ID: 24737549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
